Phe-Gly motifs drive fibrillization of TDP-43's prion-like domain condensates

PLoS Biol. 2021 Apr 28;19(4):e3001198. doi: 10.1371/journal.pbio.3001198. eCollection 2021 Apr.

Abstract

Transactive response DNA-binding Protein of 43 kDa (TDP-43) assembles various aggregate forms, including biomolecular condensates or functional and pathological amyloids, with roles in disparate scenarios (e.g., muscle regeneration versus neurodegeneration). The link between condensates and fibrils remains unclear, just as the factors controlling conformational transitions within these aggregate species: Salt- or RNA-induced droplets may evolve into fibrils or remain in the droplet form, suggesting distinct end point species of different aggregation pathways. Using microscopy and NMR methods, we unexpectedly observed in vitro droplet formation in the absence of salts or RNAs and provided visual evidence for fibrillization at the droplet surface/solvent interface but not the droplet interior. Our NMR analyses unambiguously uncovered a distinct amyloid conformation in which Phe-Gly motifs are key elements of the reconstituted fibril form, suggesting a pivotal role for these residues in creating the fibril core. This contrasts the minor participation of Phe-Gly motifs in initiation of the droplet form. Our results point to an intrinsic (i.e., non-induced) aggregation pathway that may exist over a broad range of conditions and illustrate structural features that distinguishes between aggregate forms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Amyloid / chemistry
  • Amyloid / metabolism
  • Chemical Precipitation
  • DNA-Binding Proteins / chemistry*
  • DNA-Binding Proteins / metabolism*
  • Dipeptides / chemistry*
  • Dipeptides / physiology
  • Humans
  • Hydrogen-Ion Concentration
  • Protein Aggregates*
  • Protein Aggregation, Pathological / metabolism
  • Protein Aggregation, Pathological / pathology
  • Protein Interaction Domains and Motifs / physiology
  • Solvents / chemistry
  • Solvents / pharmacology

Substances

  • Amyloid
  • DNA-Binding Proteins
  • Dipeptides
  • Protein Aggregates
  • Solvents
  • TARDBP protein, human
  • phenylalanylglycine

Grants and funding

This work has been funded by Grants CTQ2017-84371-P to D.P.-U. and SAF2016-76678-C2-2-R to D.V.L., from the Spanish MINECO; Grant MCB1412253 from the U. S. National Science Foundation to A.E.M; AriSLA (PathensTDP project) to E.B.; and Grant LCF/BQ/PR19/11700003 from La Caixa Foundation (ID 100010434) to M.M. M.M. is a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2019-026574-I). NMR experiments were performed in the “Manuel Rico” NMR Laboratory (LMR) of the Spanish National Research Council (CSIC), a node of the Spanish Large-Scale National Facility (ICTS R-LRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.